Cita APA

Hernández, C., Arasanz Esteban, H., Chocarro de Erauso, L., Bocanegra Gondán, A. I., & Zuazo Ibarra, M. (2020). Systemic blood immune cell populations as biomarkers for the outcome of immune checkpoint inhibitor therapies.

Citación estilo Chicago

Hernández, Carlos, Hugo Arasanz Esteban, Luisa Chocarro de Erauso, Ana Isabel Bocanegra Gondán, y Miren Zuazo Ibarra. Systemic Blood Immune Cell Populations As Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. 2020.

Cita MLA

Hernández, Carlos, et al. Systemic Blood Immune Cell Populations As Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. 2020.